|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. |
| 公司地址
| Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435 |
| 電話號碼
| +32 10222355 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.nyxoah.com |
| 員工數量
| 153 |
| Mr. John Landry |
Chief Financial Officer |
-- |
26/03/2026 |
| Mr. Olivier Taelman |
Chief Executive Officer and Director |
歐元 426.99K |
26/03/2026 |
| Mr. Bruno Onkelinx |
Chief Technology Officer |
-- |
26/03/2026 |
| Mr. Scott Holstine |
Chief Commercial Officer |
-- |
26/03/2026 |
|
|
| Mr. Kevin Rakin |
Independent Director |
26/03/2026 |
| Ms. Virginia M. Kirby |
Independent Director |
26/03/2026 |
| Mr. Daniel George Wildman |
Independent Director |
26/03/2026 |
| Dr. Pierre Gianello, M.D. |
Director |
26/03/2026 |
| Mr. Olivier Taelman |
Chief Executive Officer and Director |
26/03/2026 |
| Ms. Rita F. Johnson-Mills |
Independent Director |
26/03/2026 |
| Mr. Robert Taub |
Non-Executive Chairman of the Board |
26/03/2026 |
| Dr. Jurgen Hambrecht, PhD |
Independent Director |
26/03/2026 |
|
|
|
|
